Dosage & Administration
Dosage Form Tablet, chewable Route of Administration Oral Visual Identification A white, round, bevelled edged tablet, plain on one side and embossed with "WL 478" on the other
Mylanta 2go Antacid Double Strength
FDA Label NDC 84177-0801
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Media Networks Sydney Pty Limited for the product Mylanta 2go Antacid Double Strength (NDC 84177-0801). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding dosage & administration, warnings, inactive ingredient, indications & usage, otc - keep out of reach of children, otc - purpose, otc - active ingredient, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Warnings
Warnings No Warnings included on Record
Inactive Ingredient
Other Ingredients (Excipients) dimeticone 1000 dimeticonol Flavour magnesium stearate maize starch mannitol purified water silicon dioxide Spearmint oil sucrose
Indications & Usage
Permitted Indications No Permitted Indications included on Record
Otc - Keep Out Of Reach Of Children
Keep out of Reach of Children Section
Otc - Purpose
Specific Indications Fast relief from upset stomach, flatulence, wind pain, gastric hyperacidity, indigestion, heartburn and oesophageal reflux.
Otc - Active Ingredient
aluminium hydroxide 400 mg magnesium hydroxide 400 mg simethicone 40 mg
Package Label.Principal Display Panel
Mylanta 2go Double Strength Chewable Antacid Tablets 48 Pack
* Please review the disclaimer below.
